Sarepta Therapeutics, Inc.
$2.27B- Market cap
- $2.38B
- Debt
- +$828.97M
- Cash
- −$939.65M
Capital structure 74% equity / 26% debt · EV / Revenue 1.03x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SRPT · current priceP/S 1.08x
$22.52Latest market snapshot
Implied fair value · at MGNI's multiple
$101.01348.5% above market
20.81 SRPT revenue / share×4.85x MGNI P/S=$101.01
Market $22.52Implied $101.01
MGNI · current priceP/S 4.85x
$24.16Latest market snapshot
Implied fair value · at SRPT's multiple
$5.3977.7% below market
4.98 MGNI revenue / share×1.08x SRPT P/S=$5.39
Market $24.16Implied $5.39